Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ishares Tr0 3 MNTH TREASRY 0-3 MTH TREASURY | 270,000 | 270,000 | 0 | $27.19M | $27.19M | 16.00% | +$2.7K |
| Instil Bio, Inc.(TIL) | 391,103 | 335,000 | -56,103 | $4.02M | $22.55M | 13.27% | +$18.53M |
| Atea Pharmaceuticals, Inc.(AVIR) | 6,375,621 | 6,650,000 | +274,379 | $21.10M | $22.28M | 13.11% | +$1.17M |
| Aclaris Therapeutics, Inc.(ACRS) | 12,988,134 | 14,250,000 | +1,261,866 | $14.29M | $16.39M | 9.64% | +$2.10M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 200,000 | 175,000 | -25,000 | $18.36M | $16.07M | 9.45% | -$2.29M |
| Adverum Biotechnologies Inc | 1,966,000 | 2,268,064 | +302,064 | $13.49M | $15.92M | 9.37% | +$2.44M |
| Tectonic Therapeutic, Inc.(TECX) | 466,047 | 211,752 | -254,295 | $7.68M | $6.42M | 3.78% | -$1.26M |
| An2 Therapeutics Inc | 0 | 5,749,432 | +5,749,432 | $0 | $6.15M | 3.62% | +$6.15M |
| Reneo Pharmaceuticals Inc | 2,672,194 | 3,457,395 | +785,201 | $4.04M | $5.88M | 3.46% | +$1.84M |
| Oramed Pharmaceuticals Inc.(ORMP) | 1,349,038 | 2,186,191 | +837,153 | $3.47M | $5.33M | 3.14% | +$1.87M |
| Achilles Therapeutics PlcADS | 625,174 | 4,100,002 | +3,474,828 | $509.5K | $4.18M | 2.46% | +$3.67M |
| Whitehawk Therapeutics, Inc.(WHWK) | 0 | 2,000,000 | +2,000,000 | $0 | $4.12M | 2.42% | +$4.12M |
| Connect Biopharma Hldgs LtdADS | 2,043,248 | 2,093,232 | +49,984 | $3.11M | $3.01M | 1.77% | -$91.7K |
| PMV Pharmaceuticals, Inc.(PMVP) | 1,309,397 | 1,688,772 | +379,375 | $2.12M | $2.52M | 1.48% | +$395.0K |
| Astrotech Corp | 220,410 | 220,410 | 0 | $1.96M | $1.76M | 1.04% | -$200.6K |
| Milestone Pharmaceuticals Inc.(MIST) | 1,102,895 | 1,136,091 | +33,196 | $1.46M | $1.73M | 1.02% | +$271.0K |
| LENZ Therapeutics, Inc.(LENZ) | 63,916 | 60,000 | -3,916 | $1.11M | $1.42M | 0.84% | +$319.3K |
| Ikena Oncology Inc | 585,114 | 723,288 | +138,174 | $965.4K | $1.25M | 0.74% | +$285.9K |
| Vanda Pharmaceuticals Inc.(VNDA) | 398,280 | 228,500 | -169,780 | $2.25M | $1.07M | 0.63% | -$1.18M |
| Lisata Therapeutics, Inc.(LSTA) | 284,669 | 284,669 | 0 | $987.8K | $854.0K | 0.50% | -$133.8K |
| Pieris Pharmaceuticals Inc | 0 | 42,130 | +42,130 | $0 | $698.5K | 0.41% | +$698.5K |
| CalciMedica, Inc.(CALC) | 160,424 | 153,887 | -6,537 | $635.3K | $681.7K | 0.40% | +$46.4K |
| Allovir Inc | 603,086 | 603,086 | 0 | $436.2K | $487.6K | 0.29% | +$51.4K |
| Talis Biomedical Corp | 42,743 | 248,702 | +205,959 | $370.2K | $460.1K | 0.27% | +$89.9K |
| Vistagen Therapeutics, Inc.(VTGN) | 150,000 | 150,000 | 0 | $522.0K | $451.5K | 0.27% | -$70.5K |
| Forte Biosciences Inc | 0 | 70,468 | +70,468 | $0 | $393.9K | 0.23% | +$393.9K |
| Nextcure Inc | 276,465 | 276,465 | 0 | $439.6K | $378.8K | 0.22% | -$60.8K |
| Verrica Pharmaceuticals Inc.(VRCA) | 180,000 | 180,000 | 0 | $1.31M | $261.0K | 0.15% | -$1.05M |
| Hillevax Inc | 0 | 19,760 | +19,760 | $0 | $34.8K | 0.02% | +$34.8K |
| Athira Pharma Inc | 900,000 | 0 | -900,000 | $2.38M | $0 | — | -$2.38M |
| Design Therapeutics, Inc.(DSGN) | 421,749 | 0 | -421,749 | $1.41M | $0 | — | -$1.41M |
| Forte Biosciences Inc | 1,761,702 | 0 | -1,761,702 | $946.0K | $0 | — | -$946.0K |